Orphan Biologics Should Get Two Extra Years Of Exclusivity, NORD Says

Organization tells Rep. Waxman it still "wholeheartedly" supports his bill, but is planning its legislative approach around longer brand exclusivity.

More from Archive

More from Pink Sheet